signed Rasagiline SPE2D221D0133.pdf

This document provides details of a planned federal contract opportunity for Rasagiline Mesylate tablets. The Defense Logistics Agency intends to issue a solicitation for a national requirements contract to supply Rasagiline Mesylate 0.5MG and 1MG tablets in bottle counts of 30. The contract will have a one-year base period and four one-year options and utilize fixed pricing. The annual usage estimates will be included in the solicitation schedule. All sources may submit a proposal which will be considered. Interested parties should contact the specified individuals for any questions. The projected solicitation date is July 2020, though DLA reserves the right to issue before or after that date. Eligible government customers will include the Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs.